Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$59.53 - $85.11 $483,740 - $691,603
-8,126 Reduced 62.03%
4,975 $395,000
Q2 2023

Aug 14, 2023

SELL
$45.44 - $71.21 $174,126 - $272,876
-3,832 Reduced 22.63%
13,101 $932,000
Q1 2023

May 15, 2023

SELL
$43.88 - $52.48 $180,390 - $215,745
-4,111 Reduced 19.54%
16,933 $848,000
Q4 2022

Feb 14, 2023

SELL
$40.82 - $57.75 $399,382 - $565,026
-9,784 Reduced 31.74%
21,044 $919,000
Q3 2022

Nov 14, 2022

BUY
$46.84 - $58.49 $1.44 Million - $1.8 Million
30,828 New
30,828 $1.64 Million
Q1 2022

May 16, 2022

SELL
$44.33 - $57.82 $1.04 Million - $1.36 Million
-23,556 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$40.27 - $56.99 $1.75 Million - $2.47 Million
-43,405 Reduced 64.82%
23,556 $1.05 Million
Q3 2021

Nov 15, 2021

BUY
$47.43 - $84.23 $3.18 Million - $5.64 Million
66,961 New
66,961 $3.23 Million
Q2 2021

Aug 16, 2021

SELL
$73.06 - $97.7 $533,922 - $713,991
-7,308 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$70.43 - $97.42 $514,702 - $711,945
7,308 New
7,308 $613,000
Q3 2020

Nov 16, 2020

SELL
$37.23 - $50.97 $1.56 Million - $2.13 Million
-41,838 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$28.78 - $46.83 $1.2 Million - $1.96 Million
41,838 New
41,838 $1.61 Million
Q3 2019

Nov 14, 2019

SELL
$58.58 - $83.91 $2.18 Million - $3.13 Million
-37,258 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$63.59 - $78.71 $1.72 Million - $2.13 Million
27,068 Added 265.63%
37,258 $2.81 Million
Q1 2019

May 15, 2019

SELL
$50.75 - $80.54 $93,633 - $148,596
-1,845 Reduced 15.33%
10,190 $799,000
Q4 2018

Feb 14, 2019

BUY
$52.18 - $67.93 $627,986 - $817,537
12,035 New
12,035 $676,000
Q1 2018

May 15, 2018

SELL
$26.05 - $34.5 $539,313 - $714,253
-20,703 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$24.5 - $36.01 $507,223 - $745,515
20,703
20,703 $531,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.73B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.